Table 1. Snapshot of North America Pharmaceutical Manufacturing Industry in Balanced Perspective, 2020-2027 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Industry Opportunities in North America Pharmaceutical Manufacturing Industry 32
Table 4. North America Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 40
Table 5. North America Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 49
Table 6. North America Pharmaceutical Manufacturing Industry by Age Group, 2017-2027, $ bn 56
Table 7. North America Pharmaceutical Manufacturing Industry by Therapeutic Application, 2017-2027, $ bn 61
Table 8. North America Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 71
Table 9. North America Pharmaceutical Manufacturing Industry by Distribution Channels, 2017-2027, $ bn 76
Table 10. North America Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2017-2027, $ bn 80
Table 11. North America Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn 85
Table 12. U.S. Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 89
Table 13. U.S. Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 89
Table 14. U.S. Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 89
Table 15. Canada Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 92
Table 16. Canada Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 92
Table 17. Canada Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 92
Table 18. Mexico Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 94
Table 19. Mexico Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 94
Table 20. Mexico Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 94
Table 21. Abbott Laboratories: Company Snapshot 99
Table 22. Abbott Laboratories: Business Segmentation 99
Table 23. Abbott Laboratories: Product Portfolio 100
Table 24. Abbott Laboratories: Revenue, 2017-2019, $ bn 100
Table 25. Risk Evaluation for Investing in North America Industry, 2020-2027 120
Table 26. Critical Success Factors and Key Takeaways 123

LIST OF FIGURE

Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Industry Estimation 15
Figure 4. North America Industry Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 17
Figure 5. North America Pharmaceutical Manufacturing Industry, 2017-2027, $ bn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical Manufacturing Industry 26
Figure 8. Primary Restraints and Impact Factors of North America Pharmaceutical Manufacturing Industry 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter's Fiver Forces Analysis of North America Pharmaceutical Manufacturing Industry 36
Figure 11. Breakdown of North America Pharmaceutical Manufacturing Industry by Formulation, 2020-2027, % of Revenue 41
Figure 12. Contribution to North America 2021-2027 Cumulative Revenue by Formulation, Value ($ bn) and Share (%) 41
Figure 13. North America Pharmaceutical Manufacturing Industry: Tablets, 2017-2027, $ bn 42
Figure 14. North America Pharmaceutical Manufacturing Industry: Capsules, 2017-2027, $ bn 43
Figure 15. North America Pharmaceutical Manufacturing Industry: Injectable, 2017-2027, $ bn 44
Figure 16. North America Pharmaceutical Manufacturing Industry: Sprays, 2017-2027, $ bn 45
Figure 17. North America Pharmaceutical Manufacturing Industry: Suspensions, 2017-2027, $ bn 46
Figure 18. North America Pharmaceutical Manufacturing Industry: Powders, 2017-2027, $ bn 47
Figure 19. North America Pharmaceutical Manufacturing Industry: Other Formulations, 2017-2027, $ bn 48
Figure 20. Breakdown of North America Pharmaceutical Manufacturing Industry by Route of Administration, 2020-2027, % of Revenue 50
Figure 21. Contribution to North America 2021-2027 Cumulative Revenue by Route of Administration, Value ($ bn) and Share (%) 50
Figure 22. North America Pharmaceutical Manufacturing Industry: Oral Medicine, 2017-2027, $ bn 51
Figure 23. North America Pharmaceutical Manufacturing Industry: Topical Medicine, 2017-2027, $ bn 52
Figure 24. North America Pharmaceutical Manufacturing Industry: Parenteral Medicine, 2017-2027, $ bn 53
Figure 25. North America Pharmaceutical Manufacturing Industry: Inhalations, 2017-2027, $ bn 54
Figure 26. North America Pharmaceutical Manufacturing Industry: Other Routes of Administration, 2017-2027, $ bn 55
Figure 27. Breakdown of North America Pharmaceutical Manufacturing Industry by Age Group, 2020-2027, % of Revenue 56
Figure 28. Contribution to North America 2021-2027 Cumulative Revenue by Age Group, Value ($ bn) and Share (%) 57
Figure 29. North America Pharmaceutical Manufacturing Industry: Children & Adolescents, 2017-2027, $ bn 58
Figure 30. North America Pharmaceutical Manufacturing Industry: Adults, 2017-2027, $ bn 59
Figure 31. North America Pharmaceutical Manufacturing Industry: Geriatric, 2017-2027, $ bn 60
Figure 32. Breakdown of North America Pharmaceutical Manufacturing Industry by Therapeutic Application, 2020-2027, % of Revenue 62
Figure 33. Contribution to North America 2021-2027 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 62
Figure 34. North America Pharmaceutical Manufacturing Industry: Cardiovascular Diseases, 2017-2027, $ bn 63
Figure 35. North America Pharmaceutical Manufacturing Industry: Pain, 2017-2027, $ bn 64
Figure 36. North America Pharmaceutical Manufacturing Industry: Diabetes, 2017-2027, $ bn 65
Figure 37. North America Pharmaceutical Manufacturing Industry: Cancer, 2017-2027, $ bn 66
Figure 38. North America Pharmaceutical Manufacturing Industry: Respiratory Diseases, 2017-2027, $ bn 67
Figure 39. North America Pharmaceutical Manufacturing Industry: Neurological Diseases, 2017-2027, $ bn 68
Figure 40. North America Pharmaceutical Manufacturing Industry: Orthopedics, 2017-2027, $ bn 69
Figure 41. North America Pharmaceutical Manufacturing Industry: Other Applications, 2017-2027, $ bn 70
Figure 42. Breakdown of North America Pharmaceutical Manufacturing Industry by Drug Type, 2020-2027, % of Revenue 71
Figure 43. Contribution to North America 2021-2027 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 72
Figure 44. North America Pharmaceutical Manufacturing Industry: Branded Prescription Drugs, 2017-2027, $ bn 73
Figure 45. North America Pharmaceutical Manufacturing Industry: Generic Prescription Drugs, 2017-2027, $ bn 74
Figure 46. North America Pharmaceutical Manufacturing Industry: OTC Drugs, 2017-2027, $ bn 75
Figure 47. Breakdown of North America Pharmaceutical Manufacturing Industry by Distribution Channels, 2020-2027, % of Revenue 76
Figure 48. Contribution to North America 2021-2027 Cumulative Revenue by Distribution Channels, Value ($ bn) and Share (%) 77
Figure 49. North America Pharmaceutical Manufacturing Industry: Retail Channels, 2017-2027, $ bn 78
Figure 50. North America Pharmaceutical Manufacturing Industry: Non-retail Channels, 2017-2027, $ bn 79
Figure 51. Breakdown of North America Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2020-2027, % of Revenue 81
Figure 52. Contribution to North America 2021-2027 Cumulative Revenue by Manufacturing Facility, Value ($ bn) and Share (%) 81
Figure 53. North America Pharmaceutical Manufacturing Industry: In-house Facility, 2017-2027, $ bn 82
Figure 54. North America Pharmaceutical Manufacturing Industry: Outsourced Facility, 2017-2027, $ bn 83
Figure 55. Breakdown of North America Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue 85
Figure 56. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 86
Figure 57. U.S. Pharmaceutical Manufacturing Industry, 2017-2027, $ bn 88
Figure 58. Canada Pharmaceutical Manufacturing Industry, 2017-2027, $ bn 91
Figure 59. Pharmaceutical Manufacturing Industry in Mexico, 2017-2027, $ bn 93
Figure 60. Growth Stage of North America Industrial Robot Software Industry over the Forecast Period 95